January 24, 2024

Insulin injection pen or insulin cartridge pen for diabetics

Will Weight Loss Drugs Mean Losses for CPG Companies?

CPG companies weigh in on the impact that the emerging class of weight loss drugs will have on consumption patterns and snack sales.

Dale Buss

Food Technology Magazine

Ozempic has cut through the clutter of direct-to-consumer pharmaceutical advertising on TV with a simple message: It’s magic. Setting its jingle —“O-O-O-Ozempic!”—to the tune of Pilot’s 1970s hit song, “Magic,” the drug by Danish company Novo Nordisk has turned weight loss management upside down, attracting millions of Americans with the prospect of simply popping pills to mitigate diabetes or to solve dietary challenges they may have been wrestling with for decades.

The boom in popularity of Ozempic and related drugs has created a potential new funding crisis for the American health-care system. More important and immediate for the food …

Login or Sign Up To Continue

You’ve hit your limit of free articles. Either sign in to your existing account, or sign up to be an IFT member and get access to hundreds of digital resources and articlers.

Authors

Dale Buss Writer

Dale Buss is an award-winning journalist and book author whose career has included reporting for The Wall Street Journal, where he was nominated for a Pulitzer Prize (daledbuss@aol.com).